PROSTATE
CANCER

PROSTATE CANCER

  • The most common cancer in men in the US after skin cancer
  • 2nd leading cancer death cause in the US after lung cancer
  • 248,000 new cases in men expected in the US in 2021
  • 34,000 deaths expected in the US in 2021

Prostate Cancer Research Program

  • Preclinical experiments performed in house
  • High quality preclinical data obtained
  • Promising antitumor results identified
  • Upcoming in-vivo studies
  • FDA track: upcoming request for pre-IND Meeting

CLINICAL PATH

  • Preclinical POC validation (ongoing)
  • Dossier preparation for submission of Pre-IND meeting request with FDA